| Announce Date | 12/09/2025 |
| EPS Normalized Actual | $2.9 (Beat by $0.13) |
| EPS GAAP Actual | $2.9 (Beat by $0.13) |
| Revenue Actual | $8.169B |
| Revenue Surprise | Beat by $8169M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jul 2029 | 12.76226 | 20.5 | 12.39352 | 13.11563 | 1 |
| Jul 2028 | 14.39256 | 18.18 | 14.06089 | 14.81411 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 2.91 | 2.91 | 8.169B | 4.86% | 8169M |
| FQ3 2025 (Jul 2025) | 3.55 | 3.55 | 8.497B | 6.48% | 8497M |
| FQ2 2025 (Apr 2025) | 2.07 | 2.07 | 7.621B | 100% | 7621M |
| FQ1 2025 (Jan 2025) | -2.35 | -2.35 | 6.872B | 100% | 6872M |
| FQ4 2024 (Oct 2024) | 2.34 | 2.34 | 7.772B | 100% | 7772M |
| FQ3 2024 (Jul 2024) | 5.29 | 5.29 | 7.946B | 100% | 7946M |
| FQ3 2000 (Jul 2000) | 0 | 0 | 0B | NAN% | 0M |
| FQ3 2001 (Jul 2001) | 0 | 0 | 0B | NAN% | 0M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Oct 2028) | 2.58 | -- | 2.52945 | 2.65567 | 1 |
| FQ3 2028 (Jul 2028) | 3.81 | -- | 3.73536 | 3.92175 | 1 |
| FQ2 2028 (Apr 2028) | 3.86 | -- | 3.78438 | 3.97322 | 1 |
| FQ1 2028 (Jan 2028) | 2.72 | -- | 2.66671 | 2.79978 | 1 |
| FQ4 2027 (Oct 2027) | 3.01823 | -- | 2.9591 | 3.10676 | 1 |
| FQ3 2027 (Jul 2027) | 3.65 | -- | 3.57706 | 3.75749 | 11 |
| FQ2 2027 (Apr 2027) | 3.13286 | -- | 3.07148 | 3.22475 | 1 |
| FQ1 2027 (Jan 2027) | 1.88203 | -- | 1.84065 | 1.94029 | 7 |
| FQ4 2026 (Oct 2026) | 3.01 | 3.32 | 2.94985 | 3.09864 | 9 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Oct 2028) | 8.39B | -- | 8.27B | 8.58B | 2 |
| FQ3 2028 (Jul 2028) | 9.14B | -- | 9.01B | 9.35B | 2 |
| FQ2 2028 (Apr 2028) | 9.31B | -- | 9.17B | 9.52B | 1 |
| FQ1 2028 (Jan 2028) | 8.35B | -- | 8.22B | 8.53B | 2 |
| FQ4 2027 (Oct 2027) | 8.29B | -- | 8.16B | 8.48B | 3 |
| FQ3 2027 (Jul 2027) | 9.04B | -- | 8.9B | 9.24B | 7 |
| FQ2 2027 (Apr 2027) | 8.66B | -- | 8.53B | 8.85B | 2 |
| FQ1 2027 (Jan 2027) | 7.67B | -- | 7.54B | 7.85B | 8 |
| FQ4 2026 (Oct 2026) | 8.5B | 3.91 | 8.37B | 8.69B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
6
Revenue # of Misses
0
Revenue # of in-lines
2
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 2.91 | 2.91 | 100% | |
| FQ3 2025 (Jul 2025) | 3.55 | 3.55 | 100% | |
| FQ2 2025 (Apr 2025) | 2.07 | 2.07 | 100% | |
| FQ1 2025 (Jan 2025) | -2.35 | -2.35 | 100% | |
| FQ4 2024 (Oct 2024) | 2.34 | 2.34 | 100% | |
| FQ3 2024 (Jul 2024) | 5.29 | 5.29 | 100% | |
| FQ3 2000 (Jul 2000) | 0 | 0 | NAN% | |
| FQ3 2001 (Jul 2001) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0B | $8.17B | $8169M | 100% |
| FQ3 2025 (Jul 2025) | $0B | $8.5B | $8497M | 100% |
| FQ2 2025 (Apr 2025) | $0B | $7.62B | $7621M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $6.87B | $6872M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $7.77B | $7772M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $7.95B | $7946M | 100% |
| FQ3 2000 (Jul 2000) | $0B | $0B | $0M | NAN% |
| FQ3 2001 (Jul 2001) | $0B | $0B | $0M | NAN% |